Aldosterone antagonists vs placebo or usual care
Gynaecomastia · people with chronic kidney disease requiring dialysis
Aldosterone antagonists (spironolactone or eplerenone) probably leads to higher gynaecomastia compared with control (placebo or standard care) (moderate certainty).
1 finding from 1 review
- Aldosterone antagonists for people with chronic kidney disease requiring dialysis 2021 · Cochrane Headline outcomes onlyRR 5.95 [1.93, 18.28]4 studies · 768 participantsModerate